Physical Therapists in Livingston, CA Accepting Medicare
2 Physical Therapists found. Showing 1 - 2
 Michelle Arroyo, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 468 Winton Pkwy, Livingston, CA 95334 Phone: 209-398-8749 |
Jena Mendoza, PT, DPT, OCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 468 Winton Pkwy, Livingston, CA 95334 Phone: 209-398-8740 Fax: 209-222-6185 |
News Archive
Scientists receive grant to examine brain mechanisms underlying social stress in males and females
The Center for Behavioral Neuroscience at Georgia State University has received a five-year, $3.2 million grant from the National Institute of Mental Health to investigate the neurochemical mechanisms underlying social stress in males and females.
New study examines TBI in women survivors of intimate partner violence
While the diagnoses and treatment of sport-related concussion have well-established guidelines and protocols, a new study from UBC's Okanagan campus is looking at what has previously been an understudied group-women survivors of intimate partner violence.
Alltech enters into agreement to acquire Ridley
Alltech and Ridley Inc. announced today that they have entered into a plan of arrangement agreement under which Alltech will acquire 100 percent of the outstanding stock of Ridley, one of the leading commercial animal nutrition companies in North America, for CAD $40.75 per share.
Discovery of new class of compounds may help fight hepatitis C
Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus's propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
Cipher Pharmaceuticals enrolls first patient in Phase III study of CIP-ISOTRETINOIN
Cipher Pharmaceuticals Inc. today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne.
› Verified 1 days ago